166 related articles for article (PubMed ID: 25243947)
1. Primary pancreatic choriocarcinoma revealed on FDG PET/CT.
Rao M; Chen Y; Zhu Y; Huang Z; Zhang L
Clin Nucl Med; 2015 Jan; 40(1):76-8. PubMed ID: 25243947
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT Findings of Primary Pulmonary Choriocarcinoma in a Postmenopausal Woman.
Zhang J; Dong A; Wang Y
Clin Nucl Med; 2024 Jul; 49(7):698-700. PubMed ID: 38739485
[TBL] [Abstract][Full Text] [Related]
3. A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology.
Maruoka Y; Abe K; Baba S; Isoda T; Matsuo Y; Kubo Y; Ogawa S; Yano T; Sasaki M; Honda H
Ann Nucl Med; 2012 Dec; 26(10):835-9. PubMed ID: 22893003
[TBL] [Abstract][Full Text] [Related]
4. Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up.
Chang WC; Hung YC; Shen HP; Kao CH
J Reprod Med; 2007 May; 52(5):450-2. PubMed ID: 17583253
[TBL] [Abstract][Full Text] [Related]
5. ¹⁸F-FDG PET/CT imaging for mixed germ cell tumor in the pineal region.
Park SA; Kim TY; Choi SS; Yang CY; Kim HS; Choi KH
Clin Nucl Med; 2012 Mar; 37(3):e61-3. PubMed ID: 22310274
[No Abstract] [Full Text] [Related]
6. Primary Pancreatic Choriocarcinoma With Hepatic Metastases on 18 F-FDG PET/CT.
Huang W; Qiu Y; Zhou Y; Yang Q; Kang L
Clin Nucl Med; 2023 Jun; 48(6):553-556. PubMed ID: 37083568
[TBL] [Abstract][Full Text] [Related]
7. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
8. High 18F-FDG uptake for uterine smooth muscle tumor of uncertain malignant potential.
Zhang R; Tian X; Qin L; Lu D; Shen J
Clin Nucl Med; 2015 Apr; 40(4):349-51. PubMed ID: 25674868
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic and thyroid metastases detected with 18F-FDG PET/CT in patient with colorectal cancer.
Castillo Morales V; García Alonso P; Balsa Bretón MA; Ortega Valle A; Penín González J; Pey Illera C
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):335-7. PubMed ID: 22998928
[TBL] [Abstract][Full Text] [Related]
10. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
11. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma of the uterine corpus on 18F-FDG PET/CT in a postmenopausal woman with elevated AFP.
Chen F; Yu C; You X; Mi B; Wan W
Clin Nucl Med; 2014 Sep; 39(9):803-5. PubMed ID: 24152629
[TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
Cimarelli S; Deshayes E; Mognetti T; Biron P; Desuzinges C; Rivoire M; Giammarile F
Clin Nucl Med; 2009 Jul; 34(7):449-51. PubMed ID: 19542954
[No Abstract] [Full Text] [Related]
15. Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT.
Toshikuni N; Kai K; Fujisawa M
Ann Nucl Med; 2008 Feb; 22(2):133-7. PubMed ID: 18311538
[TBL] [Abstract][Full Text] [Related]
16. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary tumor embolism from choriocarcinoma: detection with F-18 FDG positron emission tomography.
Sone T; Yoshikawa K; Fukunaga M
Clin Nucl Med; 2008 Nov; 33(11):773-4. PubMed ID: 18936610
[No Abstract] [Full Text] [Related]
18. A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.
Burge ME; O'Rourke N; Cavallucci D; Bryant R; Francesconi A; Houston K; Wyld D; Eastgate M; Finch R; Hopkins G; Thomas P; Macfarlane D
HPB (Oxford); 2015 Jul; 17(7):624-31. PubMed ID: 25929273
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG-PET/CT findings in pancreatic metastasis.
Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
[TBL] [Abstract][Full Text] [Related]
20. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
